Hidaka Y, Tada H, Amino N
Department of Laboratory Medicine, Osaka University Medical School, Suita.
Rinsho Byori. 1997 Sep;45(9):825-30.
Graves' thyrotoxicosis frequently occurs after delivery through immune rebound mechanism. We tried to establish a systematic method of predicting postpartum onset of Graves' thyrotoxicosis. We followed pregnant women with anti-thyroid microsomal antibody (MCAb) from their early pregnancy to the postpartum period, and analyzed the relation between activities of thyroid stimulating antibodies (TSAb) in early pregnancy and the postpartum occurrence of Graves' disease. Among 71 subjects with positive MCAb, 7 showed positive TSAb in their early pregnancy without any thyroid dysfunction. All 7 developed thyroid dysfunction in postpartum period. Five of seven (70% of TSAb positive subjects) developed Graves' disease. None of 64 TSAb-negative subjects developed Graves' thyrotoxicosis, though 44 developed various types of thyroid dysfunction due to postpartum autoimmune thyroiditis. Graves' thyrotoxicosis also occurs after an attack of allergic rhinitis. A patient who developed Graves' thyrotoxicosis after an attack of allergic rhinitis showed positive TSAb before the attack of allergic rhinitis. These findings suggest that high risk of Graves' thyrotoxicosis onset can be predicted by the detection of TSAb.
格雷夫斯甲状腺毒症常通过免疫反弹机制在产后发生。我们试图建立一种预测格雷夫斯甲状腺毒症产后发病的系统方法。我们对从早孕至产后阶段的抗甲状腺微粒体抗体(MCAb)阳性孕妇进行随访,并分析早孕时促甲状腺素刺激抗体(TSAb)活性与产后格雷夫斯病发生之间的关系。在71例MCAb阳性受试者中,7例在早孕时TSAb阳性且无任何甲状腺功能障碍。所有7例在产后均出现甲状腺功能障碍。7例中有5例(TSAb阳性受试者的70%)发生了格雷夫斯病。64例TSAb阴性受试者中无人发生格雷夫斯甲状腺毒症,尽管44例因产后自身免疫性甲状腺炎出现了各种类型的甲状腺功能障碍。格雷夫斯甲状腺毒症也可在过敏性鼻炎发作后发生。一名在过敏性鼻炎发作后发生格雷夫斯甲状腺毒症的患者在过敏性鼻炎发作前TSAb呈阳性。这些发现表明,通过检测TSAb可预测格雷夫斯甲状腺毒症发病的高风险。